CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
1981
75
LTM Revenue $1.7M
LTM EBITDA n/a
$29.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CollPlant has a last 12-month revenue of $1.7M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, CollPlant achieved revenue of $11.0M and an EBITDA of -$6.4M.
CollPlant expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See CollPlant valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $0.3M | $11.0M | $0.5M | $1.7M | XXX |
Gross Profit | $13.6M | -$0.1M | $9.0M | XXX | XXX |
Gross Margin | 4561% | -1% | 1988% | XXX | XXX |
EBITDA | -$16.0M | -$6.4M | n/a | n/a | XXX |
EBITDA Margin | -5358% | -58% | NaN% | 0% | XXX |
Net Profit | $0.2M | -$16.9M | -$7.0M | XXX | XXX |
Net Margin | 79% | -154% | -1556% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 10, 2025, CollPlant's stock price is $4.
CollPlant has current market cap of $41.9M, and EV of $29.8M.
See CollPlant trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$29.8M | $41.9M | XXX | XXX | XXX | XXX | $-0.98 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 10, 2025, CollPlant has market cap of $41.9M and EV of $29.8M.
CollPlant's trades at 17.6x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate CollPlant's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for CollPlant and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $29.8M | XXX | XXX | XXX |
EV/Revenue | 66.1x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | -2.5x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCollPlant's NTM/LTM revenue growth is 624%
CollPlant's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, CollPlant's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate CollPlant's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for CollPlant and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -96% | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 96% | XXX | XXX | XXX | XXX |
Opex to Revenue | 150% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Lineage Cell Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
Arovella Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
Aroa Biosurgery | XXX | XXX | XXX | XXX | XXX | XXX |
Cynata Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CollPlant acquired XXX companies to date.
Last acquisition by CollPlant was XXXXXXXX, XXXXX XXXXX XXXXXX . CollPlant acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was CollPlant founded? | CollPlant was founded in 1981. |
Where is CollPlant headquartered? | CollPlant is headquartered in United States of America. |
How many employees does CollPlant have? | As of today, CollPlant has 75 employees. |
Who is the CEO of CollPlant? | CollPlant's CEO is Mr. Eran Rotem. |
Is CollPlant publicy listed? | Yes, CollPlant is a public company listed on NAS. |
What is the stock symbol of CollPlant? | CollPlant trades under CLGN ticker. |
When did CollPlant go public? | CollPlant went public in 2021. |
Who are competitors of CollPlant? | Similar companies to CollPlant include e.g. Lineage Cell Therapeutics, Arovella Therapeutics, Aroa Biosurgery, Cynata Therapeutics. |
What is the current market cap of CollPlant? | CollPlant's current market cap is $41.9M |
What is the current revenue of CollPlant? | CollPlant's last 12-month revenue is $1.7M. |
What is the current EV/Revenue multiple of CollPlant? | Current revenue multiple of CollPlant is 17.6x. |
What is the current revenue growth of CollPlant? | CollPlant revenue growth between 2023 and 2024 was -96%. |
Is CollPlant profitable? | Yes, CollPlant is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.